相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。B cell-related gene signature and cancer immunotherapy response
Arian Lundberg et al.
BRITISH JOURNAL OF CANCER (2022)
Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer
Jun-Nan Guo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy
Myriam Ben Khelil et al.
CANCERS (2022)
Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer
Li Liu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis
Yan-Jie Chen et al.
CELL DEATH & DISEASE (2022)
Prognostic model and nomogram construction based on autophagy signatures in lower grade glioma
Chunhui Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
RIPK3 signaling and its role in the pathogenesis of cancers
Shanhui Liu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Potential role of tumor-infiltrating T-, B-lymphocytes, tumor-associated macrophages and IgA-secreting plasma cells in long-term survival in the rectal adenocarcinoma patients
Dmitry A. Zinovkin et al.
LIFE SCIENCES (2021)
The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer
Beatriz Subtil et al.
FRONTIERS IN IMMUNOLOGY (2021)
Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer
Zirui Zhao et al.
JOURNAL OF ONCOLOGY (2021)
Development of a novel necroptosis-associated miRNA risk signature to evaluate the prognosis of colon cancer patients
Yang Huang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
Danielle Maeser et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma
Ting Lei et al.
CANCER SCIENCE (2021)
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Vitaly Chasov et al.
FRONTIERS IN IMMUNOLOGY (2021)
Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
Allan Scarpitta et al.
FRONTIERS IN ONCOLOGY (2021)
Tumor Immunology and Tumor Evolution: Intertwined Histories
Jerome Galon et al.
IMMUNITY (2020)
Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5
Yohei Ando et al.
PLOS ONE (2020)
Necroptosis in Immuno-Oncology and Cancer Immunotherapy
Jenny Sprooten et al.
CELLS (2020)
The role of necroptosis in cancer biology and therapy
Yitao Gong et al.
MOLECULAR CANCER (2019)
RBCK1 contributes to chemoresistance and sternness in colorectal cancer (CRC)
Min-Li Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway
Yiwei Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics Analysis
Georgios D. Ayiomamitis et al.
CANCERS (2019)
The Prognostic Importance of CD20+ B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets
Sofia Edin et al.
SCIENTIFIC REPORTS (2019)
Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression
Kezhou Zhu et al.
CELL DEATH & DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
Lien Van Hoecke et al.
NATURE COMMUNICATIONS (2018)
Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer
Xian Li et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2017)
Natural products to prevent drug resistance in cancer chemotherapy: a review
Renyikun Yuan et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing
Abhishek D. Garg et al.
CELL DEATH AND DIFFERENTIATION (2017)
Cancer therapy in the necroptosis era
Z. Su et al.
CELL DEATH AND DIFFERENTIATION (2016)
Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis
Dominique Bozec et al.
ONCOTARGET (2016)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
Th17 Cell Plasticity and Functions in Cancer Immunity
Leslie Guery et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer
X. Feng et al.
NEOPLASMA (2015)
Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Zhenyu Cai et al.
NATURE CELL BIOLOGY (2014)
Necroptosis
Andreas Linkermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dendritic cell defects in the colorectal cancer
Annalisa Legitimo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
James M. Murphy et al.
IMMUNITY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Necroptosis as an alternative form of programmed cell death
Dana E. Christofferson et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
A Degterev et al.
NATURE CHEMICAL BIOLOGY (2005)